a
Company
HOME
ABOUT US
HOW TO SUBSCRIBE
REQUEST LISTING
MENU
HOME
ABOUT US
HOW TO SUBSCRIBE
REQUEST LISTING
CURRENT NEWS
27.01.2021
Introduction of Salmeterol / Fluticason Neutec Inhalation Powder
27.01.2021
Introduction Tramadol HCI Prolepha Retard 100Mg
27.01.2021
Security the Biggest Challenge in Domain Management as 2020 Recorded Rise in Domain-Related Cyber Attacks, Says New Clarivate Report
27.01.2021
Withdrawal of Complaint Regarding Eldecalcitol Patent by Chugai Pharmaceutical Co., Ltd
26.01.2021
Nelipak Laboratory Services Completed Validation of New Climatic Conditioning Chamber
26.01.2021
Predictive Oncology Announces Closing of $4.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
26.01.2021
Personalis Announces Pricing of Public Offering of Common Stock
26.01.2021
Sorrento Announces Positive Preliminary Results of Phase 1b Study of COVI-MSC for Treatment of ICU COVID-19 Patients
26.01.2021
Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval From FDA
26.01.2021
Personalis Announces Launch of Public Offering of Common Stock
26.01.2021
PerkinElmer Launches Industry-First GPCR TR-FRET Binding Assay and Beta-Arrestin Kits to Help Advance Therapeutics Discovery
26.01.2021
DuPont Launches SYNERXIA Gemstone Collection of New High-Performance Yeasts for U.S. Ethanol Market
26.01.2021
Aphena's 500,000-Square-Foot Expansion in Tennessee Nears Completion
26.01.2021
New Data Show Treatment With Etesevimab (JS016) and Bamlanivimab Together Reduced Risk of COVID-19 Hospitalizations and Death by 70 Percent
26.01.2021
Care Access Research Collaborates With AstraZeneca on Phase III Clinical Trial for COVID-19 Long-Acting Antibody Combination
26.01.2021
Novel SARS CoV-2 Saliva Collection Devices Address COVID-19 Testing Challenges, Improving Lab Efficiency and PCR Test Performance
26.01.2021
HCA Healthcare Uses Its COVID-19 Registry by Forming Consortium With AHRQ and Research Institutions to Accelerate COVID-19 Research
26.01.2021
X-Chem Acquires IntelliSyn and Sister Company, AviSyn, to Extend and Streamline Drug Discovery Service Range
26.01.2021
RECORDATI RARE DISEASES: CARBAGLU (Carglumic Acid) Tablets 200mg Receives U.S. FDA Approval for a New Indication to Treat Acute Hyperammonemia Associated With Propionic Acidemia and Methylmalonic Acidemia
26.01.2021
Integrity Laboratories Launches Novel Quantification Tool for COVID-19 Providers
Records per page:
Page
Total:
24267
records.
×
How to see the list